Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities
Irene Paassen(University of Bern), Jarno Drost(Utrecht University), Martine F. Roussel(St. Jude Children's Research Hospital), Marc van de Wetering(Oncode Institute), Femke Ringnalda(Oncode Institute), Kornelius Kerl(University Hospital Münster), Kimberly Mercer(St. Jude Children's Research Hospital), Mariëtte E.G. Kranendonk(Princess Máxima Center), Carla Ríos Arceo(Oncode Institute), Eelco W. Hoving(Princess Máxima Center), Hans Clevers(Hubrecht Institute for Developmental Biology and Stem Cell Research), Justin Williams(St. Jude Children's Research Hospital), N. Franke(Princess Máxima Center), Marcel Kool(German Cancer Research Center), Santhosh A. Upadhyaya(University of Michigan), Natalia Moreno(University Hospital Münster), Aniello Federico(German Cancer Research Center), Juliane L. Buhl(German Cancer Research Center)
Cited by 37